Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,530,726
+$207,735 QoQ
Shares Held
6,083
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#2,157
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Ellis Asset Management LLC holds $17,156,761 across 7 Drug Manufacturers - General names. ABBV ranks #6 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,547 | $4,254,378 | |
| 2 | SNY |
Sanofi
|
81,342 | $3,470,049 | |
| 3 | JNJ |
Johnson & Johnson
|
13,294 | $3,376,277 | |
| 4 | NVS |
Novartis AG
|
14,950 | $2,342,964 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,988 | $1,925,958 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
6,083 | $1,530,726 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,450 | $256,409 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,530,726 | 6,083 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,322,991 | 6,083 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,399,044 | 6,123 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,496,906 | 6,465 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,214,511 | 6,543 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,494,715 | 7,134 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,278,196 | 7,193 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,450,095 | 7,343 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,158,617 | 6,755 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,230,085 | 6,755 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,122,757 | 7,245 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1,078,150 | 7,233 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,057,495 | 7,849 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,314,643 | 8,249 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,349,281 | 8,349 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,147,898 | 8,553 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,290,066 | 8,423 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,299,960 | 8,019 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,085,772 | 8,019 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $865,009 | 8,019 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $859,330 | 7,629 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $836,432 | 7,729 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $846,913 | 7,904 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $700,194 | 7,994 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $797,123 | 8,119 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $618,586 | 8,119 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||